Evaluation of the Biosafety of lead substitutes Used in the Manufacture of Unleaded Crystal Glass

Projektinformationen

ID Finanzhilfevereinbarung: BRST950030

Projekt abgeschlossen

Startdatum 27 Juli 1995

Enddatum 12 Juni 1996

Finanziert unter

• Specific research and technological development programme in the field of industrial and materials technologies, 1994-1998

Gesamtkosten € 0,00

EU-Beitrag Keine Daten

Koordiniert durch

Royal Brierley Crystal
United Kingdom

Ziel

Currently crystal glass contains either 24% or 32% lead. In use, lead may leach from crystal into liquids which may be subsequently drunk, resulting in lead intake by the general public. This intake is regarded as unacceptable by groups in some countries (e.g. USA) and therefore there is pressure to remove lead from crystal and replace it with G safer substitute. Whilst a lot is known about lead toxicity, relatively little is known the bioavailability, toxicity and behaviour of substitutes in the body The aim of the project is to provide the European Crystal Industry with the biological information for the production of a safety case for genetic unleaded crystal compositions.

Wissenschaftliches Gebiet

• engineering and technology › materials engineering

Programm/Programme

• FP4-BRITE/EURAM 3 - Specific research and technological development programme in the field of industrial and materials technologies, 1994-1998

Thema/Themen

• 0102 - Development of clean production technologies

Aufforderung zur Vorschlagseinreichung

Data not available

Finanzierungsplan

EAW - Exploratory awards

Koordinator

Royal Brierley Crystal

• EU-Beitrag: Keine Daten
• Adresse: North Street ; DY5 3SJ Brierley Hill ; Vereinigtes Königreich
• Gesamtkosten: Keine Daten